Targeting ERK5 for colorectal cancer therapy
Ended Project Grant Awarded Last action
- Award ID
- R21CA244691
- Recipient
-
Phusis Therapeutics, Inc. UEI JGZFBDAL61C4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $752,435
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $582,965.98 Federal
- $169,469.00 Non-federal
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$29,460 | $0 | |
| Amendment | -$156,152 | $0 | |
| Amendment | $156,152 | $0 | |
| Amendment | -$156,152 | $0 | |
| Amendment | $156,152 | $0 | |
| Amendment | -$156,152 | $0 | |
| Amendment | $156,152 | $0 | |
| Amendment | $169,469 | $0 | |
| Amendment | $169,469 | $169,469 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $273,488 | $0 |
Show all 12
Quick answers
Who received award R21CA244691?
R21CA244691 was awarded to Phusis Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on May 13, 2020.
How much is award R21CA244691 worth?
$752,435 has been obligated on R21CA244691: $582,966 in federal funding and $169,469 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award